PPT-Prevention of Coronary Heart Disease with Pravastatin in Me

James Shepherd MD Stuart M Cobbe MD Ian Ford PhD Christopher G Isles MD A Ross Lorimer MD Peter W Macfarlane Ph D James H McKillop MD and Christopher J Packard D Sc for the West of Scotland Coronary Prevention Study Group. A Disease of Affluence . Lesson Objectives. I understand what CHD is. I understand what ‘affluence’ factors contribute to CHD. I know what the distribution of CHD is within the world and the UK. I know what the effects of CHD are . Christopher Whitty. Gresham College 2015. The medical importance of the heart had not been realised in Thomas Gresham’s day (d 1597) . .. De . Motu. . Cordis. . (1628). William Harvey1578-1657 . For much of the last 50 years the heart has grown old before the rest of the body.. Presented at Late Breaking Clinical Trials. AHA 2002. PROSPER. PROSPER. 5,804 high-risk elderly patients . Age 70–82 years. Pre-existing vascular disease (coronary, cerebral, or peripheral) . High-risk for vascular disease (smoking, hypertension, or diabetes). James Shepherd, M.D., Stuart M. Cobbe, M.D., Ian Ford, Ph.D., Christopher G. Isles., M.D., A. Ross Lorimer, M.D., Peter W. Macfarlane, Ph. D., James H. McKillop, M.D., and Christopher J. Packard, D. Sc., for the West of Scotland Coronary Prevention Study Group. Presented at Late Breaking Clinical Trials. AHA 2002. PROSPER. PROSPER. 5,804 high-risk elderly patients . Age 70–82 years. Pre-existing vascular disease (coronary, cerebral, or peripheral) . High-risk for vascular disease (smoking, hypertension, or diabetes). Coronary Artery Disease. Group 1: Kritika Badhan, Hannah Kearney, Muhammad Mateen, Vyshnavi Mahendran, and Wardha Wardha. Table of Contents. What is the Global Burden of Disease? . Overview of Coronary Artery Disease (CAD). Shaista Malik, MD, PhD, MPH, FACC. Associate Professor. Medical Director, Preventive Cardiology and . Cardiac Rehab Program. Director, Women’s Heart Disease Program. University of California, Irvine. Tanveer Rab, MD, FACC. Perwaiz M. Meraj, MD, FACC. Starting a Complex Coronary . Intervention Program. Does your hospital have the volume?. Buy in from administration and your colleagues. Is there a will to invest? . worldwide with age being the . most important . non-modifiable . risk . factor. . Prevalence of CAD in adults under 30 has been estimated to be very low . (Fig. 1. ), . however its true prevalence is unknown.. Coronary heart disease (CHD) is caused by a narrowing of the blood vessels to the heart. This reduces the flow of blood to the heart.. If one of the blood vessels becomes completely blocked, the blood supply to part of the heart stops and is damaged. This is called a heart attack.. Kassy. McMahon, RN (BScN) . Statistics . Heart disease is the second leading cause of death in both males and females in Canada. . Men are 2 times more likely to suffer a heart attack than women.. Approximately 2.4 million Canadians live with. Rajesh . Tota-Maharaj. , Michael J . Blaha. , . Ron . Blankstein. , . Leslee. J Shaw, . Roger . S Blumenthal, . Matthew . J . Budoff. , . Khurram. . Nasir. .. No disclosures for this presentation.. ,. Associate Professor, Pathology. Sri Venkateswara Institute of Medical Sciences. Trupathi. ISCHEMIC HEART DISEASE (IHD). IHD represents a group of . pathophysiologically. related syndromes resulting from myocardial ischemia – an . Heart and circulatory disease is the UK's biggest killer.  In 2001, cardiovascular disease caused 40% of deaths in the UK, and killed over 245,000 people.. . Death rates for heart disease have been falling rapidly in the UK since the late 1970s. Despite this, death rates from CHD in the UK are still amongst the highest in the world.  .